Brigham and Women's Hospital is an Comprehensive Cancer Center located in Boston, MA. The International Mesothelioma Program at Brigham has pioneered surgical techniques and led landmark research that has shaped global treatment standards.
Last verified: 2026-03-09The International Mesothelioma Program at Brigham and Women's Hospital was founded by Dr. David Sugarbaker and continues under the leadership of Dr. Raphael Bueno. The program has treated thousands of mesothelioma patients and has one of the largest published surgical outcome databases. The program integrates thoracic surgery, medical oncology (through Dana-Farber), radiation therapy, and translational research into a comprehensive treatment approach.
The Brigham program is historically associated with extrapleural pneumonectomy (EPP) combined with chemotherapy and radiation — a trimodality approach pioneered here. Under Dr. Bueno's leadership, the program also offers pleurectomy with decortication, cytoreductive surgery with HIPEC for peritoneal mesothelioma, and innovative immunotherapy clinical trials. The choice of surgical approach is individualized based on tumor stage and patient factors.
Our team can help connect you with mesothelioma specialists at Brigham and Women's Hospital and explain your treatment options and legal rights.
Call 617-732-5500 or Dana-Farber at 866-408-3324 for appointments. The International Mesothelioma Program offers patient coordinators, second opinion services, and social work support. Patient lodging is available through the Hope Lodge and local hotel partnerships. Dana-Farber's Patient and Family Support Programs provide counseling, support groups, and financial assistance.
Phone: 617-732-5500
Website: brighamandwomens.org/
Address: 75 Francis St, Boston, MA 02115
The International Mesothelioma Program at Brigham and Women's Hospital is one of the world's most recognized mesothelioma treatment programs, founded by Dr. David Sugarbaker. It has treated thousands of patients and published landmark research on mesothelioma surgery.
The program is led by Dr. Raphael Bueno, Chief of Thoracic Surgery, who has published extensively on mesothelioma genetics, surgical outcomes, and novel therapeutic approaches.
Yes. Brigham and Women's Hospital and Dana-Farber Cancer Institute have a formal partnership. Mesothelioma patients receive surgical care at Brigham and medical oncology, chemotherapy, and immunotherapy through Dana-Farber's thoracic oncology team.
Brigham and Women's Hospital (Dana-Farber/Brigham Cancer Center) in Boston, MA is an NCI-designated Comprehensive Cancer Center offering mesothelioma treatment including surgery, chemotherapy, immunotherapy, and clinical trials. Contact the center directly to schedule a consultation or request a second opinion.
Brigham and Women's Hospital (Dana-Farber/Brigham Cancer Center) in Boston is widely recognized as a leading mesothelioma treatment center in Massachusetts. As an NCI-designated Comprehensive Cancer Center, it offers specialized surgery, chemotherapy, immunotherapy, and clinical trials for mesothelioma patients.
If you or a loved one has been treated at Brigham and Women's Hospital for mesothelioma, our legal team can help you pursue the compensation you deserve while you focus on treatment. Contact us for a free, confidential consultation.
Or call us 24/7: 1-800-400-1805
Information last verified: 2026-03-09
Sources:
